Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05703022
Other study ID # Interventional
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date November 30, 2021
Est. completion date June 30, 2025

Study information

Verified date January 2023
Source University Hospital of North Norway
Contact Margrethe Müller, MSc
Phone 004777655893
Email margrethemuller@unn.no
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

A prospective, interventional, single-group, single centre study to evaluate the feasibility of early aerobic exercise training in patients following heart valve surgery for infective endocarditis.


Description:

Infective endocarditis (IE)is uncommon, but people with some heart conditions have a greater risk of developing it. Well designed studies have shown that the majority of the IE population have low physical function and many are inactive. This is negative for their health and well-being. High-intensity aerobic interval training has shown to be beneficial in patients with other cardiovascular disorders. Presumably, patients with IE also benefit from such treatment, but the optimal training mode,intensity, frequency and duration to improve aerobic capacity are not clear. This study will explore how aerobic interval training supported by smartwatch may contribute to the physical activity after infective endocarditis . Throughout the project, investigators will explore opportunities and barriers for supervised individualised exercise training for IE patients that has been treated with heart valve surgery. The primary objective is to explore how early aerobic interval training can be safely performed and accepted in patients with infective endocarditis after heart valve surgery. The two main research questions are: 1. How is aerobic interval training experienced by patients with IE after heart-valve surgery? 2. Can aerobic interval training with smartwatch support be accepted and safely performed by patients who have undergone endocarditis and left-sided heart-valve surgery? The study is a single centre feasibility study, at the University Hospital of North Norway in Tromsø .The study duration from the first assessment of the first patient to the last assesment of the last patient: 24 months. The in-hospital training intervention for each patient will start between 7 and 21 days after the heart valve surgery and continue in university or local hospital for 3 months. Investigators will recruit between 10 and 20 participants from the University Hospital of North Norway.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date June 30, 2025
Est. primary completion date October 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 99 Years
Eligibility Inclusion Criteria: - (1)patients presenting with confirmed infectious endocarditis, with left-sided heart valve surgery and without arterial embolus, - (2)being residents of Northern Norway, - (3)willing and able to give informed consent 4-21 days after the heart valve surgery. Exclusion Criteria: - (1)patients who are hemodynamically or respiratory unstable, have temperature > 38 or positive blood cultures - (2)clinically significant serious concurrents medical condition such as premorbid illnesses and other concurrens serious infection which could affect the safety or tolerability of the intervention - (3)clinically significant concurrens musculoskeletal disorder or other concurrent disease or injury that may inhibit physical activity.

Study Design


Intervention

Other:
Aerobic interval training
The intervention will start between 7 and 21 days after heart valve surgery. While hospitalized the participants will perform supervised aerobic interval training comprised 4x4 minute, 3 times per week. Intensity will start at 60% of maximum heart rate in the first week, around 13-14 in Borg RPE-Scale. The workload will be gradually increased as the participant tolerance improves, but not above 85% of maximum heart rate or 16-17 in Borg RPE Scale.

Locations

Country Name City State
Norway University Hospital of North Norway Tromsø

Sponsors (4)

Lead Sponsor Collaborator
University Hospital of North Norway Herlev and Gentofte Hospital, Norwegian University of Science and Technology, UiT The Arctic University of Norway

Country where clinical trial is conducted

Norway, 

Outcome

Type Measure Description Time frame Safety issue
Other HeartQOL Health-related quality of life assessed by The Norwegian version of Heart QOl for patients with coronary heart disease with scale 0-3, where 3= A lot heart problems and 0=No problems Changes from baseline in heart /health-related quality of life at 3 months
Other EQ5D-5L Health status assessed by The Norwegian version of EQ-5D-5L with EQ Visual Analogue scale (EQ VAS) 0-100, where 0=worst health and 100=best health Changes from baseline in health-related quality of life at 3 months
Other New cardiovascular or cerebrovascular incidents. Gathered from participants and their electronic journal system 3 months
Primary Feasibility of inhospital aerobic interval training Number of completely finished training sessions will be record. 3 months
Primary Experience with inhospital aerobic inetrval training assessed by semi structured interviews Semi structured interviews will involve patients opinions on the strengths and weaknesses of the inhospital training intervention. Before discharge
Primary Experience with inhospital aerobic inetrval training assessed by semi structured interviews Semi structured interviews will involve patients experiences of adopting and following the trainings program at home. 3 months
Secondary Intervention related endpoints 1 Number of training sessions During intervention
Secondary Intervention related endpoints 2 Duration of training sessions During intervention
Secondary Intervention related endpoints 3 Intensity of training sessions: Speed on the treadmill, bicycel or step box During intervention
Secondary Intervention related endpoints 4 Exercise method. During intervention
Secondary Patient related endpoints 1 Peak heart rate measured with Apple Watch During intervention
Secondary Patient related endpoints 2 Atrial fibrillation episodes will be measured with Apple Watch During intervention
Secondary Patient related endpoints 3 Blood pressure wil be measured before and after training sessions During intervention
Secondary Patient related endpoints 4 Borg RPE-Scale During intervention
Secondary Sub-maximal oxygen uptake A graded treadmill test of sub-maximal oxygen uptake using a breath by breath ergospirometer Sub-maximal oxygen uptake at 2 weeks
Secondary Sub-maximal oxygen uptake A graded treadmill test of sub-maximal oxygen uptake using a breath by breath ergospirometer Sub-maximal oxygen uptake at 3 months
Secondary 6 minute walk test Walking distance (in meters) will be measured with the 6 minute walk test 6 minute walk test at 2 weeks
Secondary 6 minute walk test Walking distance (in meters) will be measured with the 6 minute walk test 6 minute walk test at 3 months
Secondary Physical Activity Axivity AX3 Accelerometers Physical activity 2 weeks
Secondary Physical Activity Axivity AX3 Accelerometers Physical activity 3 months.
Secondary Experience with inhospital aerobic - Questionaire The questionnaire will contain validated questions from the PasOpp questionnaire along with questions specifically prepared for this study on process and experience outcomes. Before discharge
Secondary Experience with inhospital aerobic - Questionaire The questionnaire will contain validated questions from the PasOpp questionnaire along with questions specifically prepared for this study on process and experience outcomes. 3 months.
Secondary Physical Activity Apple Watch Physical activity at 2 weeks
Secondary Physical Activity Apple Watch Physical activity at 3 months
See also
  Status Clinical Trial Phase
Not yet recruiting NCT02865798 - China Senile Valvular Heart Disease Cohort Study N/A
Completed NCT02249000 - BIOVALVE - I / II Clincial Investigation N/A
Completed NCT02297334 - Removal of Cytokines During Extracorporeal Circulation in Cardiac Surgery N/A
Completed NCT01591018 - SONOlysis in Risk REduction of Symptomatic and Silent Brain infarCtions dUring Cardiac surgEry Phase 3
Completed NCT01428947 - Does Coronary Angiography Cause Cognitive Dysfunction? N/A
Recruiting NCT01231776 - Acupuncture Improves Sleep in Patients Undergoing Cardiopulmonary Bypass N/A
Terminated NCT01116037 - ATS 3f(r) Aortic Bioprosthesis Model 1000 Post Approval Study N/A
Completed NCT00371891 - Ontario Multidetector Computed Tomographic (MDCT) Coronary Angiography Study (OMCAS) Phase 4
Terminated NCT03632967 - Early Feasibility Study of the Percutaneous 4Tech TriCinch Coil Tricuspid Valve Repair System N/A
Recruiting NCT05728047 - Evaluation of Systemic Microcirculation of Patients Undergoing Heart Valve Surgery
Not yet recruiting NCT05539261 - Research on Neurological Prognosis of Patients Undergoing Heart Valve Surgery
Completed NCT05479968 - Spectroscopic Assessment of Intramyocardial Oxygen Saturation Feasibility During Open-heart Surgery
Completed NCT03527381 - Nitric Oxide in Cardiopulmonary Bypass for Renal Protection in Cardiac Surgery Phase 1/Phase 2
Completed NCT03664102 - Automated Fastener Device Versus Manually Tied Knot in MiAVR
Recruiting NCT06084091 - Spectroscopic Assessment of Intramyocardial Oxygen Saturation During Open-Heart Surgery
Completed NCT05836467 - Is Myocardial Revascularization Really Necessary in Patients With ≥50-70% Coronary Stenosis Undergoing Valvular Surgery?
Recruiting NCT05933083 - MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation N/A
Recruiting NCT04445012 - Cardiovascular Acoustics and an Intelligent Stethoscope
Active, not recruiting NCT02732691 - JENAVALVE AS EFS TRIAL: Pericardial TAVR Aortic Stenosis Study N/A
Completed NCT02981953 - TRI-REPAIR: TrIcuspid Regurgitation RePAIr With CaRdioband Transcatheter System N/A